Table 2.
Pain intensity.
| Pain intensity | Total (n=118) | MEOPAa group (n=60) | VRb group (n=58) | P valuec | |||
| 15 minutes after the biopsy | |||||||
|
|
Pain intensity, mean (SD) | 3.3 (2.5) | 3.5 (2.6) | 3.0 (2.4) | .27 | ||
|
|
Pain, median (range) | 3.0 (0-10) | 3.0 (0-10) | 3.0 (0-10) | N/Ad | ||
|
|
Pain, 95% CI | –1.6 to 8.2 | –1.596 to 8.596 | –1.704 to 7.704 | N/A | ||
| 1 month after the biopsy | |||||||
|
|
Completed questionnaires, n (%) | 104 (88.1) | 52 (86.7) | 52 (89.7) | N/A | ||
|
|
Residual pain, median (range) | 0 (0-5) | 0 (0-3) | 0 (0-5) | .51 | ||
|
|
Memory of pain, n (%) | .37 | |||||
|
|
|
Yes | 26 (25.0) | 15 (28.9) | 11 (21.1) |
|
|
|
|
|
No | 78 (75.0) | 37 (71.1) | 41 (78.9) |
|
|
|
|
Evaluation of memory (analog visual scale), median (range) | 3 (1-10) | 3 (1-8) | 5 (1-10) | .31 | ||
aMEOPA: mixture of nitrous oxide/oxygen.
bVR: virtual reality.
ct test, except for memory of pain, which was assessed using a chi-square test.
dN/A: not assessed.